{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T02:10:19Z","timestamp":1758852619984,"version":"3.44.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"DOI":"10.7759\/cureus.93221","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:39:30Z","timestamp":1758850770000},"source":"Crossref","is-referenced-by-count":0,"title":["Permissive Hypoxemia With Partial Pressure of Oxygen in Arterial Blood (PaO2) at Less Than 50 mmHg: A Case of Successful Ventilator Weaning for COVID-19-Associated Acute Respiratory Failure"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwonil","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia","volume":"62","author":"Abdelsalam M","year":"2017","unstructured":"Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia. Respir Care. 2017, 62:1454-63.","journal-title":"Respir Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009931.pub2","article-title":"Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients","volume":"2014","author":"Gilbert-Kawai ET","year":"2014","unstructured":"Gilbert-Kawai ET, Mitchell K, Martin D, Carlisle J, Grocott MP. Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients. Cochrane Database Syst Rev. 2014, 2014:CD009931. 10.1002\/14651858.CD009931.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.03.002","article-title":"Oxygenation target in acute respiratory distress syndrome","volume":"3","author":"Capellier G","year":"2023","unstructured":"Capellier G, Barrot L, Winizewski H. Oxygenation target in acute respiratory distress syndrome. J Intensive Med. 2023, 3:220-7. 10.1016\/j.jointm.2023.03.002","journal-title":"J Intensive Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.03.58","article-title":"Permissive hypoxemia\/conservative oxygenation strategy: Dr. Jekyll or Mr. Hyde?","volume":"8","author":"He HW","year":"2016","unstructured":"He HW, Liu DW. Permissive hypoxemia\/conservative oxygenation strategy: Dr. Jekyll or Mr. Hyde?. J Thorac Dis. 2016, 8:748-50. 10.21037\/jtd.2016.03.58","journal-title":"J Thorac Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin MJ","year":"2020","unstructured":"Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020, 202:356-60. 10.1164\/rccm.202006-2157CP","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01462-5","article-title":"The pathophysiology of 'happy' hypoxemia in COVID-19","volume":"21","author":"Dhont S","year":"2020","unstructured":"Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir Res. 2020, 21:198. 10.1186\/s12931-020-01462-5","journal-title":"Respir Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis","volume":"12","author":"Zhang T","year":"2021","unstructured":"Zhang T, Shen P, Duan C, Gao L. KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2021, 12:745233. 10.3389\/fimmu.2021.745233","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00018","article-title":"Surfactant protein D in respiratory and non-respiratory diseases","volume":"5","author":"Sorensen GL","year":"2018","unstructured":"Sorensen GL. Surfactant protein D in respiratory and non-respiratory diseases. Front Med (Lausanne). 2018, 5:18. 10.3389\/fmed.2018.00018","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1450798","article-title":"Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis","volume":"16","author":"He X","year":"2025","unstructured":"He X, Ji J, Zheng D, Luo Z, Luo L, Guo L. Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2025, 16:1450798. 10.3389\/fimmu.2025.1450798","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.745634","article-title":"Happy or silent hypoxia in COVID-19--a misnomer born in the pandemic era","volume":"12","author":"Akoumianaki E","year":"2021","unstructured":"Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or silent hypoxia in COVID-19--a misnomer born in the pandemic era. Front Physiol. 2021, 12:745634. 10.3389\/fphys.2021.745634","journal-title":"Front Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916431","article-title":"Liberal or conservative oxygen therapy for acute respiratory distress syndrome","volume":"382","author":"Barrot L","year":"2020","unstructured":"Barrot L, Asfar P, Mauny F, et al.. Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med. 2020, 382:999-1008. 10.1056\/NEJMoa1916431","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032510","article-title":"Lower or higher oxygenation targets for acute hypoxemic respiratory failure","volume":"384","author":"Schj\u00f8rring OL","year":"2021","unstructured":"Schj\u00f8rring OL, Klitgaard TL, Perner A, et al.. Lower or higher oxygenation targets for acute hypoxemic respiratory failure. N Engl J Med. 2021, 384:1301-11. 10.1056\/NEJMoa2032510","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406925-permissive-hypoxemia-with-partial-pressure-of-oxygen-in-arterial-blood-pao2-at-less-than-50-mmhg-a-case-of-successful-ventilator-weaning-for-covid-19-associated-acute-respiratory-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:39:31Z","timestamp":1758850771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406925-permissive-hypoxemia-with-partial-pressure-of-oxygen-in-arterial-blood-pao2-at-less-than-50-mmhg-a-case-of-successful-ventilator-weaning-for-covid-19-associated-acute-respiratory-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.93221","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}